Missense variants, although more functionally unclear, in CHEK2, ATM, TP53, BRCA1, and BRCA2 also showed evidence of association with overall breast cancer risk (odds ratio of 1.06 to 1.42) [47]. Here, TP53 is linked to breast carcinoma.